At a glance
ClinicalIndex Comparison Record- ✓Women aged 18-50 years
- ✓Undergoing cesarean delivery at the study institution
- ✕Major post-surgical complications including cesarean hysterectomy, bowel or bladder injury, reoperation, ICU admission, or wound infection/separation
- ✕Chronic opioid use (buprenorphine during pregnancy or opioid use >7 days during pregnancy)
- ✕Non-English or non-Spanish speaking
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial to Improve Discharge Opioid Prescribing After Cesarean Delivery
In Brief
A clinical study evaluating Tailored prescription and Control for Surgery and Opioid Use. Completed, enrolled 190 participants across 1 site.
Detailed Summary
The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion. Adjusting post- cesarean delivery opioid prescribing practices to better match actual patient need has the potential to reduce unused opioids available for diversion, nonmedical use, and development of chronic dependence, as well as reduce wasted resources.
Study Details
Timeline
Interventions
Participants will be prescribed an opioid tablet number based on a formula derived from inpatient opioid use
Participants will be prescribed 30 tablets of oxycodone 5mg